Background-Noncardiac surgery after percutaneous coronary intervention (PCI) has been reported to be carrying high risk for both ischemic and bleeding complications. However, there has been no report comparing the incidence and outcomes of surgical procedures after coronary artery bypass grafting (CABG) with those after PCI. Methods and Results-Among 14 383 patients undergoing first coronary revascularization (PCI, n=12 207; CABG, n=2176) enrolled in the Coronary Revascularization Demonstrating Outcome Study in Kyoto (CREDO-Kyoto) PCI/CABG Registry Cohort-2, surgical procedures were performed more frequently after CABG (n=560) than after PCI (n=2398; cumulative 3-year incidence: 27% versus 22%; unadjusted P<0.0001), particularly <6 months of coronary revascularization. The risk for the primary ischemic outcome measure (death/myocardial infarction) at 30-day postsurgical procedures was not significantly different between the CABG and PCI groups (cumulative incidence: 3.1% versus 3.2%; unadjusted P=0.9; adjusted hazard ratio, 0.97; 95% confidence interval, 0.47-1.89; P=0.9). The risk for the primary bleeding outcome measure (moderate or severe bleeding by Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries classification) was lower in the CABG groups than in the PCI group (cumulative incidence: 1.3% versus 2.6%; unadjusted P=0.07; adjusted hazard ratio, 0.36; 95% confidence interval, 0.12-0.87; P=0.02). There were no interactions between the timing of surgery and the types of coronary revascularization (CABG/PCI) for both ischemic and bleeding outcomes. Conclusions-Surgical procedures were performed significantly more frequently after CABG than after PCI, particularly <6 months after coronary revascularization. Surgical procedures after CABG as compared with those after PCI were associated with similar risk for ischemic events and lower risk for bleeding events, regardless of the timing after coronary revascularization. (Circ Cardiovasc Interv. 2014;7:482-491.)
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N oncardiac surgery after coronary stent implantation, early surgery in particular, has been reported to be carrying a high risk for both ischemic and bleeding events perioperatively. [1] [2] [3] [4] [5] [6] Therefore, the current guidelines recommend delaying elective surgical procedures for ≤6 weeks after bare-metal stent implantation and 1 year after drug-eluting stents (DES) implantation. In patients with complex coronary artery disease scheduled for elective surgical procedures, coronary artery bypass grafting (CABG) rather than percutaneous coronary intervention (PCI) is preferred, although the role of prophylactic coronary revascularization before noncardiac surgery in patients with stable coronary artery disease is controversial in the current guidelines. 7, 8 Indeed, the 2 randomized controlled trials (Coronary Artery Revascularization Prophylaxis [CARP] trial and Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo [DECREASE]-V pilot study) could not demonstrate the protective effect of prophylactic coronary revascularization on death or myocardial infarction (MI) after major vascular surgery. 9, 10 The mortality rate after noncardiac surgical procedures in patients with prior CABG was reported to be low in several previous studies. 9, [11] [12] [13] [14] [15] [16] However, there has been no large-scale study comparing the incidence and outcomes of surgical procedures after CABG with those after PCI.
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Therefore, we sought to evaluate the incidence and outcomes of surgical procedures after CABG as compared with those after PCI in a large Japanese observational database.
Methods

Study Population
The Coronary Revascularization Demonstrating Outcome Study in Kyoto (CREDO-Kyoto) PCI/CABG registry cohort-2 is a physicianinitiated non-company-sponsored multicenter registry enrolling consecutive patients undergoing first coronary revascularization among 26 centers in Japan between January 2005 and December 2007. The relevant review boards or ethics committees in all 26 participating centers (Appendix A in the Data Supplement) approved the research protocol. Because of retrospective enrollment, written informed consents from the patients were waived; however, we excluded those patients who refused study participation when contacted for follow-up.
The study design and patient enrollment of CREDO-Kyoto PCI/ CABG registry cohort-2 were previously described in detail. 17 Among 15 939 patients enrolled in this registry, the study population for the current analysis consisted of 14 383 patients (PCI group, 12 207 patients; CABG group, 2176 patients), excluding 67 patients who refused study participation, 880 PCI patients treated without stent, and 609 CABG patients who underwent combined noncoronary surgery. During follow-up after the index coronary revascularization procedures, non-CABG surgical procedures were performed in 2958 patients (PCI group, 2398 patients; CABG group, 560 patients; Figure 1 ). Clinical outcomes after surgery in the PCI group were previously reported focusing on the influences of timing of surgery, types of stents (DES versus bare-metal stents), and perioperative status of antiplatelet therapy (APT) on outcomes. 1 In the current analysis, we compared the incidence and outcomes of surgical procedures between PCI and CABG groups.
Definitions
Surgical procedures during follow-up excluding CABG were captured as follow-up events after PCI and CABG. Surgical procedures were defined as the procedures performed under general, spinal, or local anesthesia. Percutaneous endovascular procedures were not regarded as surgical procedures, because these procedures were generally performed under intravenous anticoagulation and without interruption of APT. On the contrary, gastrointestinal endoscopic therapeutic procedures were included in the surgical procedures, because antiplatelet agents are often interrupted before the procedures. 18 We excluded those surgical procedures related to the index PCI such as vascular repair and those related to mechanical complications of acute MI at presentation, as well as those related to the index CABG such as rethoracotomy. The type of anesthesia (general/spinal versus local anesthesia) was regarded as a surrogate for major versus minor surgery. The timing of the surgical procedures after stent implantation and CABG was categorized into 2 prespecified subgroups (early surgery: <42 days after coronary revascularization; late surgery: >42 days after coronary revascularization) based on the previous reports suggesting increased risk for adverse events in patients undergoing surgical procedures <30 days to 90 days after bare-metal stents 2, 3 and DES implantation. 1, [4] [5] [6] The recommended APT regimen was aspirin (≥81 mg daily) indefinitely after both PCI and CABG, and thienopyridine (200 mg ticlopidine or 75 mg clopidogrel daily) for at least 1 month after bare-metal stent implantation and for ≤3 months after DES implantation. The duration of dual APT and management of perioperative APT was left to the discretion of each attending physician. Data on status of APT were collected throughout the follow-up period. Status of perioperative APT was classified into 3 groups (dual, single, and no APT) according to the status on the day before the surgical procedures.
Clinical and procedural characteristics and medications were not evaluated at the time of surgical procedures, but were evaluated at the time of index coronary revascularization procedures.
End Points
The primary outcome measure for ischemic events was a composite of death or MI, whereas the primary outcome measure for bleeding events was moderate or severe bleeding by Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries classification. 19 Primary outcome measures were assessed at 30 days after the surgical procedures. Individual components of the primary ischemic outcome measure were also evaluated.
WHAT IS KNOWN
• Noncardiac surgery after percutaneous coronary intervention may result in ischemic and bleeding complications.
• There has been no large-scale study comparing the incidence and outcomes of surgical procedures after coronary artery bypass grafting with those after percutaneous coronary intervention.
WHAT THE STUDY ADDS
• Surgical procedures were performed significantly more frequently after coronary artery bypass grafting than after percutaneous coronary intervention, particularly <6 months after coronary revascularization.
• Surgical procedures after coronary artery bypass grafting as compared with those after percutaneous coronary intervention were associated with similar risk for ischemic events and lower risk for bleeding events, regardless of the timing after coronary revascularization.
Demographic, angiographic, and procedural data were collected from hospital charts or hospital databases according to prespecified definitions by experienced clinical research coordinators who belonged to the Research Institute for Production Development, Kyoto, Japan (see Appendix B in the Data Supplement). Follow-up data were obtained from hospital charts or by contacting patients or referring physicians. Clinical events such as death, MI, stent thrombosis, and bleeding were adjudicated by the clinical event committee (Appendix C in the Data Supplement).
Median follow-up duration for the surviving patients was 952 (interquartile range, 692-1261) days. Complete 30-day follow-up information after the surgical procedure was available in 2842 (CABG, 540; PCI, 2302) patients (96.4%) out of 2958 eligible patients.
Statistical Analysis
Descriptive statistics are presented as frequency (percentage) for categorical variables and mean±SD or median (interquartile range) for continuous variables. These values were compared between patients who underwent CABG and PCI using a χ 2 or Fisher exact test for categorical variables and using a 2-sample t test or Wilcoxon rank-sum test for continuous variables. Cumulative incidences of the surgical procedures after the index coronary revascularization procedures and the clinical events after the surgical procedures were estimated by the Kaplan-Meier method, and differences were assessed with the log-rank test. A landmark analysis for the cumulative incidences of surgical procedures was conducted at 6 months after CABG or PCI in patients who were alive and free from the surgical procedures at the 6-month landmark point. We made an analysis for the cumulative incidence of surgical procedures adjusting for the baseline differences by using a Cox proportional hazard model. We also constructed a multivariable Cox proportional hazard model with administrative censoring at 1 year after the index CABG or the PCI procedure to identify independent predictors for the occurrence of surgical procedures <1 year after the index PCI and CABG procedures. Variables indicated in Table I in the Data Supplement were used as potential independent predictors. The continuous variables were dichotomized by clinically meaningful reference values or median values.
The adjusted covariates for the effects of prior CABG relative to prior PCI on the primary outcome measures were evaluated by multivariable Cox proportional hazard models. In consistent with our prior report, 1 potential independent risk-adjusting variables in the Cox models were indicated in Table I in the Data Supplement. Independent correlates for the primary outcome measures were identified by a backward elimination procedure. The final model incorporated prior CABG, status of perioperative APT, as well as types of anesthesia (general/spinal versus local anesthesia) and timing of surgery (<42 days versus >42 days after the index coronary revascularization) together with those variables remaining after the backward procedure. The effects of prior CABG were expressed as hazard ratios (HR) and their 95% confidence intervals (CIs). Subgroup analyses regarding the timing of surgery (<42 days versus >42 days) and the types of anesthesia (general/spinal versus local anesthesia) were also conducted for the primary outcome measures by using the Cox proportional hazard models with interaction terms between those subgroup factors and the index procedures (CABG or PCI). As sensitivity analyses, we also adopted 30-day and 365-day cut-off point for the subgroup analyses regarding the timing of surgery.
All analyses were conducted with the use of JMP 8.0 (SAS Institute Inc, Cary, NC). All the statistical analyses were 2-tailed, and P values <0.05 were considered statistically significant.
Results
Baseline Characteristics and Medications: CABG Versus PCI
As compared with patients in the PCI group, patients in the CABG group more often had diabetes mellitus, heart failure, multivessel coronary artery disease, prior MI, prior stroke, peripheral vascular disease, renal failure, atrial fibrillation, and anemia, whereas patients in the PCI group more often had acute coronary syndrome presentation, emergency procedures, and current smoking ( Table 1; Table I in the Data Supplement). Regarding the procedural characteristics, DES was used in 56% of patients and the number of target lesions was 1.5±0.77 in the PCI group, wheras the left internal mammary graft was used in the vast majority of patients with off-pump CABG in 62% of patients, and the number of anastomoses was 3.23±1.08 in the CABG group (Table I in 
Incidence and Predictors of Surgical Procedures: CABG Versus PCI
During the 3-year follow-up after PCI and CABG, surgical procedures were performed significantly more frequently after CABG than after PCI (27% versus 22% at 3 years; log-rank P<0.0001; Figure 2A ). Even after adjusting the differences in the baseline characteristics, CABG as compared with PCI was associated with significantly higher incidence of surgical procedures (HR, 1.15; 95% CI, 1.03-1.29; P=0.02; Table II in the Data Supplement). The cumulative incidence of surgical procedures was significantly higher after CABG than after PCI within the first 6 months (P<0.0001), whereas it was not significantly different >6 months between the 2 groups (P=0.4; Figure 2B ).
The differences in baseline characteristics and medications between CABG and PCI groups in patients who underwent surgical procedures during follow-up were generally consistent with those in the entire cohort of patients (Table III in the Data Supplement).
Early surgery <42 days after coronary revascularization was more common in the CABG group than in the PCI group (26% versus 15%; P<0.0001), whereas the prevalence of general/spinal anesthesia was similar between the 2 groups (50% Table 2 ). Regarding the fields of surgery, vascular surgery was most common in both groups, particularly in the CABG group. Other common surgical fields included abdominal surgery, ophthalmic surgery, and gastrointestinal endoscopic procedures in both groups (Table 3) . Among the surgical procedures performed <6 months after the index coronary revascularization, the proportion of vascular surgery was greater after CABG than after PCI (31.1% versus 24.0%; Table IV in the Data Supplement). Scheduled repair of abdominal aortic aneurysm was particularly common after CABG.
Independent predictors of surgical procedures within the first year after CABG identified by the multivariable Cox proportional hazard model were similar to those after PCI, including advanced age, malignancy, and peripheral vascular disease ( Table V in 
Clinical Outcome After Surgical Procedures: CABG Versus PCI
The cumulative incidence of the primary outcome measure for ischemic events at 30 days after surgical procedures was similar between CABG and PCI groups (3.1% versus 3.2%; P=0.9), whereas that for bleeding events trended to be lower in the CABG group than in the PCI group (1.3% versus 2.6%; P=0.07; Figures 3 and 4) . After adjusting confounders, the Death was the dominant component of the primary ischemic outcome measure in both groups, whereas the proportion of MI was low in both groups ( Table 4 ). The proportion of cardiac death was similar between the 2 groups. However, 21 (51%) out of 41 cardiac deaths in the PCI group were related to the complications of MI that had already occurred before surgery (Table 5 ).
Subgroup Analyses: Early Versus Late Surgery, and Major Versus Minor Surgery
A subgroup analysis was performed according to the timing of surgery after the index coronary revascularization procedures. In patients who underwent early surgery <42 days after the index coronary revascularization procedures, cumulative incidences of both ischemic and bleeding outcome measures at 30 days after surgical procedures were significantly higher in the PCI group than in the CABG group (9.3% versus 4.1%; P=0.049 and 6.7% versus 1.4%; P=0.02). After adjusting potential confounders, the lower risk of prior CABG relative to prior PCI for the ischemic outcome measure was no longer significant (HR, 1.15; 95% CI, 0.34-3.39; P=0.8), whereas the lower risk of prior CABG relative to prior PCI for bleeding outcome measure remained significant (HR, 0.13; 95% CI, 0.01-0.76; P=0.02; Figure 5 ; Tables VIII, and IV in the Data Supplement). In patients who underwent late surgery >42 days after the index coronary revascularization procedures, cumulative incidences of both the ischemic and bleeding outcome measures at 30 days after surgical procedures were not different between the PCI and CABG groups (2.1% versus 2.7%; P=0.4, and 1.9% versus 1.3%; P=0.3). After adjusting potential confounders, the risks of prior CABG relative to prior PCI for both the ischemic and bleeding outcome measures remained insignificant (HR, 1.54; 95% CI, 0.67-3.24; P=0.3, and HR, 0.65; 95% CI, 0.19-1.68; P=0.4; Figure 5 ; Tables X and XI in the Data Supplement). There were no interactions between the timing of surgery and the types of coronary revascularization modalities (CABG/PCI) for both ischemic and bleeding outcomes ( Figure 5 ).
The results of sensitivity analyses, in which the definition of early surgery was changed to surgery <30 days or <365 days after the index coronary revascularization procedures, were consistent with the results described above using the definition of <42 days ( Figure 5 ).
Regarding the risk profiles of surgical procedures, the risk for ischemic outcome measure after major surgery trended to be higher in the CABG group than in the PCI group, whereas it was similar after minor surgery in both CABG and PCI groups. However, there was no interaction between the risk profiles of surgical procedures and the types of coronary revascularization modalities (CABG/PCI). The risk for bleeding outcome measure trended to be lower in the CABG group than in the PCI group in both major and minor surgical procedures ( Figure 5 ).
Discussion
The main findings of this study are as follows: (1) Surgical procedures were performed significantly more frequently after CABG than after PCI, particularly <6 months after the index coronary revascularization procedure. (2) The risk for ischemic events <30 days after surgery was not different between the 2 groups of patients with prior PCI and prior CABG, whereas the risk for bleeding events was significantly lower in patients with prior CABG than in patients with prior PCI. (3) Even in patients who underwent early surgery <42 days after the index coronary revascularization procedures, the risk for ischemic events was not different between the 2 groups of patients with prior PCI and prior CABG.
There was no previous report evaluating the cumulative incidence of noncardiac surgical procedures after CABG. In the current study, surgical procedures were performed significantly more frequently after CABG than after PCI. Because the cumulative incidence of surgical procedures >6 months after coronary revascularization was not different between the PCI and CABG groups, it seemed unlikely that baseline characteristics of CABG patients were more prone to the need for surgical procedures than those of PCI patients. One of the biggest limitations in the current study was that we could not distinguish those surgical procedures scheduled before coronary revascularization from those needed after coronary revascularization. Nevertheless, it seems plausible that patients scheduled for surgical procedures after coronary revascularization were more likely to undergo CABG rather than PCI, because early surgical procedures after coronary stent implantation, DES in particular, were reported to be associated with prohibitive risk for both ischemic and bleeding complications. 1, 4, 5 The mortality rate after noncardiac surgical procedures in patients with prior CABG was reported to be low in several previous studies. 9, [11] [12] [13] [14] [15] [16] However, there has been no large-scale study that systematically evaluated the outcomes of surgical procedures after CABG as compared with those after PCI. In the current study, the risk of PCI patients relative to CABG patients for ischemic complications after surgical procedures was demonstrated to be insignificant. Although PCI patients who underwent early surgical procedures had higher rates of ischemic complications compared with CABG patients, we previously reported that higher risk in early surgery after PCI might not be related to the timing after stent implantation per se, but related to more morbid preoperative conditions in patients who underwent early surgery. 21 Clinical presentation as acute MI at the time of index coronary revascularization was significantly more prevalent in patients receiving PCI than in patients receiving CABG. After adjusting potential confounders including initial acute MI presentation, the higher risk of PCI relative to CABG was no longer significant even in patients who underwent early surgical procedures. In line with our report, Rabbitts et al 22 reported that the risk of major adverse cardiovascular events with noncardiac surgery after DES implantation was not significantly associated with time from stenting to surgery. Furthermore, a recent retrospective cohort study of 41 989 operations in the 24 months after a coronary stent implantation also demonstrated that emergency surgery and history of recent MI were more important in predicting adverse events after surgery than the timing after stent implantation. 23 Regarding the early surgical procedure after CABG, Breen et al 24 reported that patients undergoing major vascular surgery within a month of CABG were associated with significantly higher perioperative mortality as compared with the case-matched controls who underwent surgery >1 month after CABG. However, Mookadam et al 25 described 211 patients who underwent noncardiac surgery <1 year after CABG and reported that when emergency operations were excluded from the analysis the length of time between CABG and noncardiac surgery did not affect the rate of adverse outcomes. Noncardiac surgery performed <2 weeks after CABG was associated with high risk for clinically significant adverse outcomes, but 95% of those were emergency procedures. Therefore, in both after PCI and CABG, the risk for perioperative adverse cardiovascular events seemed to be more dependent on preoperative morbidities rather than the time from coronary revascularization.
On the contrary, the risk for bleeding was significantly higher after PCI than after CABG. The higher bleeding risk of PCI patients could be related to the fact that PCI patients were more often on perioperative dual APT compared with CABG patients. As we have previously reported, maintenance of perioperative dual APT increased bleeding complications without decreasing ischemic complications. 1 Perioperative bleeding complications could be reduced with more appropriate perioperative management of APT. Therefore, both PCI and CABG could be viable options in patients who are scheduled for noncardiac surgery after coronary revascularization.
Study Limitations
There are several important limitations in this study. Among the study limitations described in our previous report, 1 one of the biggest issues pertinent to the current analysis was that we did not collect data on the clinical status at the time of surgical procedures, particularly urgency of the surgical procedures, which would be a critical determinant of clinical outcome after surgical procedures. Furthermore, we could not distinguish those surgical procedures scheduled before coronary revascularization from those needed after coronary revascularization. The proportion of surgical procedures scheduled before coronary revascularization could be different between the PCI and CABG groups. Also, there were unmeasured confounders such as frailty and cognitive dysfunction in the selection of CABG or PCI, which might have impacted on the incidence and outcome of surgical procedures after CABG and PCI. Finally, this is a descriptive report and not a test of superiority of either PCI or CABG.
Conclusions
Surgical procedures were performed significantly more frequently after CABG than after PCI, particularly <6 months after the index coronary revascularization. Surgical procedures after CABG as compared with those after PCI were associated with similar risk for ischemic events and lower risk for bleeding events, regardless of the timing after coronary revascularization.
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Supplemental Table 1 Continuous variables are shown as mean ± SD or median (Interquartile range). †potential independent variables selected only for adjusting the 30-day outcomes after surgical procedures, ‡potential independent variables selected only in the analysis of the independent predictors for the occurrence of surgical procedures within 1 year after the index PCI and CABG procedures, and *potential independent variables selected for both analyses. 
